Jade Biosciences, Inc. · NASDAQ:JBIO
Jade Biosciences, Inc. shareholders
As of Sep 30, 2026, 156 institutions reported holding Jade Biosciences, Inc. Largest: Fidelity, Janus Henderson and Paradigm Biocapital Advisors LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Jade Biosciences, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 9.81M | +683K | Nov 10, 2026 | |
| Janus Henderson | 6.99M | first report | Nov 16, 2026 | |
| Paradigm Biocapital Advisors LP | 6.05M | +3.2M | Nov 16, 2026 | |
| Fairmount Funds Management LLC | 4.55M | no change | Nov 16, 2026 | |
| Bellevue Group AG | 4.29M | +1.24M | Nov 16, 2026 | |
| Franklin Templeton | 3.81M | +1.02M | Nov 12, 2026 | |
| BlackRock | 3.37M | +565K | Nov 13, 2026 | |
| Vanguard | 3.3M | +211K | Nov 13, 2026 | |
| Venrock Adviser, LLC | 3.22M | no change | Nov 16, 2026 | |
| State Street | 2.6M | +268K | Nov 12, 2026 |